Summary
Latest filing:
Sumita Ray is Chief Legal Compliance Officer of Cue Biopharma, Inc. (CUE). 3 SEC Form 4 filings on record, most recently on 17 August 2026. Most recent open-market trade: sold $125 of CUE on 17 August 2026. Lifetime open-market sales: $266K.
Recent Transactions
5Every recent SEC Form 4 transaction Sumita Ray has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Sumita Ray files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $2.61M of CUE open-market activity in the last 12 months
- Michael Vincent Meluzio - $169K of CUE open-market activity in the last 12 months
- Pasha Sarraf - $100K of CUE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Sumita Ray?
Sumita Ray is a corporate insider, tracked as Chief Legal Compliance Officer of Cue Biopharma, Inc. (CUE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sumita Ray submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Sumita Ray been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($266K) across all tracked filings.
Where can I see all of Sumita Ray's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Sumita Ray and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
